EP1230394A4 - Vektortransduktion hematopoietischer stammzellen mittels lentivirus - Google Patents

Vektortransduktion hematopoietischer stammzellen mittels lentivirus

Info

Publication number
EP1230394A4
EP1230394A4 EP00978485A EP00978485A EP1230394A4 EP 1230394 A4 EP1230394 A4 EP 1230394A4 EP 00978485 A EP00978485 A EP 00978485A EP 00978485 A EP00978485 A EP 00978485A EP 1230394 A4 EP1230394 A4 EP 1230394A4
Authority
EP
European Patent Office
Prior art keywords
stem cells
hematopoietic stem
lentiviral vector
vector transduction
transduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00978485A
Other languages
English (en)
French (fr)
Other versions
EP1230394A1 (de
Inventor
Wen Yong Chen
Xiaoyun Wu
John C Kappes
Tim M Townes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Publication of EP1230394A1 publication Critical patent/EP1230394A1/de
Publication of EP1230394A4 publication Critical patent/EP1230394A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/16045—Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP00978485A 1999-11-10 2000-11-10 Vektortransduktion hematopoietischer stammzellen mittels lentivirus Withdrawn EP1230394A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16462599P 1999-11-10 1999-11-10
US164625P 1999-11-10
PCT/US2000/030882 WO2001034843A1 (en) 1999-11-10 2000-11-10 Lentiviral vector transduction of hematopoietic stem cells

Publications (2)

Publication Number Publication Date
EP1230394A1 EP1230394A1 (de) 2002-08-14
EP1230394A4 true EP1230394A4 (de) 2002-12-18

Family

ID=22595350

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00978485A Withdrawn EP1230394A4 (de) 1999-11-10 2000-11-10 Vektortransduktion hematopoietischer stammzellen mittels lentivirus

Country Status (5)

Country Link
EP (1) EP1230394A4 (de)
JP (1) JP2003517301A (de)
AU (1) AU784988B2 (de)
CA (1) CA2391129A1 (de)
WO (1) WO2001034843A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
IL160132A0 (en) 2001-08-02 2004-06-20 Inst Clayton De La Rech Methods and compositions relating to improved lentiviral vector production systems
EP1438075A4 (de) 2001-10-02 2006-04-19 Inst Clayton De La Rech Verfahren und zusammensetzungen in verbindung mit lentiviralen vektoren mit begrenzter expression und ihre anwendungen
DE60331297D1 (de) 2002-03-07 2010-04-01 Univ Delaware Verfahren zur verstärkung der oligonucleotid-vermittelten nucleinsäuresequenzänderung unter verwendung von zusammensetzungen mit einem hydroxyharnstoff
SG190997A1 (en) 2010-12-09 2013-07-31 Univ Pennsylvania Use of chimeric antigen receptor-modified t cells to treat cancer
EP2661489A4 (de) * 2011-01-03 2014-09-10 Bluebird Bio Inc Verfahren zur verstärkung der abgabe gen-transduzierter zellen
UY35468A (es) 2013-03-16 2014-10-31 Novartis Ag Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
DK3129470T3 (da) 2014-04-07 2021-07-05 Novartis Ag Behandling af cancer ved anvendelse af anti-CD19-kimær antigenreceptor
WO2015183885A1 (en) * 2014-05-27 2015-12-03 Dana-Farber Cancer Institute, Inc. Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
HUE059218T2 (hu) 2015-04-08 2022-11-28 Novartis Ag CD20-terápiák, CD22-terápiák és kombinációs terápiák CD19 kiméra antigénreceptort (CAR-t) expresszáló sejttel
CN110114077A (zh) * 2016-09-13 2019-08-09 中央研究院 藉移植增加寿命及/或治疗细胞增殖疾病的方法
TW202340473A (zh) 2016-10-07 2023-10-16 瑞士商諾華公司 利用嵌合抗原受體之癌症治療
US11597917B2 (en) 2017-07-06 2023-03-07 The Medical College Of Wisconsin, Inc. In vitro and in vivo enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO0134843A1 *

Also Published As

Publication number Publication date
EP1230394A1 (de) 2002-08-14
CA2391129A1 (en) 2001-05-17
WO2001034843A1 (en) 2001-05-17
AU1594401A (en) 2001-06-06
AU784988B2 (en) 2006-08-17
JP2003517301A (ja) 2003-05-27

Similar Documents

Publication Publication Date Title
AU8694701A (en) Methods for stable transduction of cells with viral vectors
GB2399572B (en) Hematopoietic cells from human embryonic stem cells
GB9900396D0 (en) Arrangements of electrochemical cells
IL156132A0 (en) Transfection of human embryonic stem cells
EP1230394A4 (de) Vektortransduktion hematopoietischer stammzellen mittels lentivirus
TW391280U (en) Structural improvement of handle band
HUP0105168A3 (en) Transplantation of haematopoietic cells
AU6330199A (en) Electrochemical synthesis of perfluoroalkylfluorophosphoranes
AU5866800A (en) Soft diving stick
GB9900398D0 (en) Arrangements of electrochemical cells
PL354679A1 (en) Hold arrangement structure of general purpose cargo vessel
AU4207899A (en) Lentiviral vector compositions and methods of use
IL155413A0 (en) Hematopoietic stem cell gene therapy
EP1032271A4 (de) Entfernen von stammzellprodukten
TW528209U (en) Improved structure of battery vessel
AU5977499A (en) Use of epinastine as antitussivum
IL125843A0 (en) Transplantation of hematopoietic cells
AUPQ775300A0 (en) Mobilisation of haemopoietic stem cells
TW500102U (en) Improved structure of container
TW527019U (en) Improved structure of cubic cell
GB9905999D0 (en) Interface microinjection - automated microinjection of single cells
TW389248U (en) Improved structure of surfboard
TW414066U (en) Improved structure of handle
TW412994U (en) Improved structure of water container
GB9820930D0 (en) Micro-injection of cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020610

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20021107

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/11 A, 7C 12N 15/63 B, 7C 12N 15/85 B, 7C 12N 15/86 B, 7C 12Q 1/68 B, 7A 61K 48/00 B, 7A 61K 35/00 B, 7C 07H 21/04 B

17Q First examination report despatched

Effective date: 20040524

17Q First examination report despatched

Effective date: 20040524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070116